These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38727610)

  • 1. Fosfomycin as a Potential Therapeutic Option in Nonsevere Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: Need for Evidence.
    Falcone M; Tiseo G
    Clin Infect Dis; 2024 May; ():. PubMed ID: 38727610
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of Fosfomycin-Containing Regimens in Reducing Mortality From Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales.
    Assimakopoulos SF; Marangos M
    Clin Infect Dis; 2024 May; ():. PubMed ID: 38727612
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of Fosfomycin Resistance Among Enterobacterales Isolates in A Tertiary Care Hospital from Turkey.
    Tanrıverdi-Çaycı Y; Güne DB; Ertokatlı M; Hacıeminoğlu-Ülker K; Birinci A
    Infect Dis Clin Microbiol; 2022 Dec; 4(4):252-257. PubMed ID: 38633718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing
    Merad Y; Conrad A; Brosset S; Schmidt A; Hanriat C; Lustig S; Laurent F; Kolenda C; Roussel-Gaillard T; Batailler C; Ferry T;
    Front Med (Lausanne); 2023; 10():1224922. PubMed ID: 37601796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased zinc levels facilitate phenotypic detection of ceftazidime-avibactam resistance in metallo-β-lactamase-producing Gram-negative bacteria.
    Simon M; Gerlach RG; Pfeifer Y; Pfennigwerth N; Gatermann SG; Schröder A; Hiergeist A; Hamprecht A; Rügamer T; Gessner A; Jantsch J
    Front Microbiol; 2022; 13():977330. PubMed ID: 36483203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain.
    Vázquez-Ucha JC; Alonso-Garcia I; Guijarro-Sánchez P; Lasarte-Monterrubio C; Álvarez-Fraga L; Cendón-Esteve A; Outeda M; Maceiras R; Peña-Escolano A; Martínez-Guitián M; Arca-Suárez J; Bou G; Beceiro A;
    Int J Antimicrob Agents; 2023 Apr; 61(4):106738. PubMed ID: 36736925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reviewing novel treatment options for carbapenem-resistant
    Mackow NA; van Duin D
    Expert Rev Anti Infect Ther; 2024; 22(1-3):71-85. PubMed ID: 38183224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases.
    Mauri C; Maraolo AE; Di Bella S; Luzzaro F; Principe L
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439062
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Cervino I; Gonzalez D; Nastro M; Vega J; Reyes AP; Buriano G; Vay C; Famiglietti A; Rodriguez CH
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34605763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing
    Falcone M; Tiseo G; Antonelli A; Giordano C; Di Pilato V; Bertolucci P; Parisio EM; Leonildi A; Aiezza N; Baccani I; Tagliaferri E; Righi L; Forni S; Sani S; Mechi MT; Pieralli F; Barnini S; Rossolini GM; Menichetti F
    Open Forum Infect Dis; 2020 Feb; 7(2):ofaa011. PubMed ID: 32042848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive
    Zalacain M; Lozano C; Llanos A; Sprynski N; Valmont T; De Piano C; Davies D; Leiris S; Sable C; Ledoux A; Morrissey I; Lemonnier M; Everett M
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019-2020).
    Boattini M; Comini S; Bianco G; Iannaccone M; Casale R; Cavallo R; Costa C
    J Chemother; 2023 May; 35(3):198-204. PubMed ID: 35731718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H
    Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
    Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New β-Lactam-β-Lactamase Inhibitor Combinations.
    Yahav D; Giske CG; Grāmatniece A; Abodakpi H; Tam VH; Leibovici L
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33177185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases.
    Le Terrier C; Nordmann P; Poirel L
    J Antimicrob Chemother; 2022 Dec; 78(1):101-107. PubMed ID: 36308322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive analysis of infections due to New Delhi metallo-β-lactamase-producing Enterobacterales in children at Red Cross War Memorial Children's Hospital.
    Greybe L; Nuttall JJC; Brink AJ; Tootla HD
    S Afr J Infect Dis; 2022; 37(1):440. PubMed ID: 35935170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Delhi Metallo-Beta-Lactamase Facilitates the Emergence of Cefiderocol Resistance in Enterobacter cloacae.
    Nurjadi D; Kocer K; Chanthalangsy Q; Klein S; Heeg K; Boutin S
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0201121. PubMed ID: 34871093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019.
    Rossolini GM; Stone G; Kantecki M; Arhin FF
    J Glob Antimicrob Resist; 2022 Sep; 30():214-221. PubMed ID: 35760303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Frequency of New Delhi Metallo-beta-Lactamase and Klebsiella pneumoniae Carbapenemase Resistant Genes in a Set of Population of Karachi.
    Afridi FI; Sani AI; Khan R; Baig S; Zaidi SAA; Jamal Q
    J Coll Physicians Surg Pak; 2023 Jan; 33(1):59-65. PubMed ID: 36597237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study.
    Larcher R; Laffont-Lozes P; Roger C; Doncesco R; Groul-Viaud C; Martin A; Loubet P; Lavigne JP; Pantel A; Sotto A
    Front Cell Infect Microbiol; 2022; 12():1048633. PubMed ID: 36544909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.